Phase 4 Completed N=224 Randomized Double-blind Treatment

IV Dexketoprofen vs Placebo in Migranie Attack

Migraine

Source: ClinicalTrials.gov NCT02159547 ↗

Enrolled (actual)

224

Serious AEs

0.0%

Results posted

Jul 2015

Primary outcomePrimary: Visual Analogue Scale Change — 55; 30 units on a scale

Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

Outcome Measures

Outcome	Result	p-value
PRIMARY Visual Analogue Scale Change	55; 30	—
SECONDARY Adverse Effects	0; 0	—

Eligibility Criteria

Inclusion Criteria

patients presented with headache who diagnosed as migraine attack according to the international headache society

Exclusion Criteria

denied to give inform concent, illiterate patients, chronic renal failure, taking NSAIDs during the last six hours, pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02159547). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.